Drugs: Pressemitteilungen - Kategorie - Seite 39

Drugs

Category / Pharmaceuticals & Biotech / Drugs


AurimMed Pharma Receives Epilepsy Foundation's Inaugural Award

PARK CITY, UT: PARK CITY, UT -- (Marketwired) -- 07/16/13 -- AurimMed Pharma, Inc., a biopharmaceutical company with an innovative approach to R&D and a unique Central Nervous System compound, has been named th ...

Selway Capital Acquisition Corporation Announces Extension of Tender Offer for Series B Shares

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 07/15/13 -- Selway Capital Acquisition Corporation (OTCQB: SWCB) (OTCQB: SWCAL) ("Selway") today announced that it has extended the expiration of its previo ...

Sirona Biochem's Skin Lightening Compounds Demonstrate Significant Antioxidant Properties

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/15/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB), announced today its skin lightening compounds have shown to have si ...

Acura Pharmaceuticals to Develop Improved NEXAFED(R)

PALATINE, IL: IMPEDE(R) 2.0 Reduces One-Pot Methamphetamine Yield to Near Zero ...

SciClone Appoints Wilson W. Cheung as Chief Financial Officer

FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 07/15/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Wilson W. Cheung as Chief Financial Officer and Senior Vice President, ...

Theravance to Report Second Quarter 2013 Financial Results on July 25, 2013

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/11/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended June 30, 2013 after market close on ...

Sirona Biochem Announces LOI for Collaboration with Biogalenys

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/02/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) is pleased to announce the signing of a Letter of Intent (LOI) for a ...

The Medicines Company Announces Positive Results for Solo II Trial of Oritavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

PARSIPPANY, NJ: SOLO II Trial Meets All Protocol-Specified Endpoints Comparing Oritavancin, Given as One Single Dose, to Vancomycin Given Twice-Daily for 7-10 Days Intravenously; Combined SOLO I and SOLO II Findings ...

Biologix Hair Inc. Set to Launch Commercial Treatment Operations, Opening Prototype Certified Biologix Hair Therapy Center(TM)

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/01/13 -- Biologix Hair Inc. (OTCBB: BLGX)(OTCQB: BLGX) is pleased to report that the company's wholly owned subsidiary, Biologix Hair Science Ltd.™, int ...

Biologix Hair Inc. Reports on Annual General Meeting Held June 28, 2013

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 06/28/13 -- Biologix Hair Inc. (OTCBB: BLGX) (OTCQB: BLGX) announces that today the Company held its 2013 Annual Meeting of Stockholders ("AGM") at its ...

Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 06/27/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:David Hung, M.D., president and chief executive off ...

Healthcare Corporation of America Names Experienced Corporate Attorney Mark Carlesimo as General Counsel

DENVILLE, NJ: DENVILLE, NJ -- (Marketwired) -- 06/27/13 -- Healthcare Corporation of America (OTCQB: SWCAL), a pharmacy-benefit management company, has announced that respected attorney Mark Carlesimo has been app ...

Theravance to Present at the 8th Annual JMP Securities Healthcare Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/26/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at t ...

Rapid Micro Biosystems Secures $32.6 Million in Series B Financing

BEDFORD, MA: Longitude Capital and TPG Biotech Lead Investment With Participation From Existing Investors ...

NuPathe to Present ZECUITY Data at the 2013 International Headache Congress

CONSHOHOCKEN, PA: Data Analyses to Be Presented Include: Efficacy of ZECUITY in Migraine Patients With and Without Nausea at Baseline Incidence of Treatment-Emergent Nausea During a Migraine Treated With ZECUITY Compar ...

Sirona Biochem Announces LOI for Collaboration with VitamFero

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/25/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) is pleased to announce the signing of a Letter of Intent (LOI) to cr ...

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status

LAGUNA HILLS, CA: LAGUNA HILLS, CA -- (Marketwired) -- 06/25/13 -- Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam® cold remedy, are pleased to announce the Company has commenced ...

IsoRay Announces a New International Distributor in Australia and New Zealand

RICHLAND, WA: Aurora BioScience Pty Ltd Sees Exciting Opportunity in Offering IsoRay's Total Product Line ...

SciClone and Taiwan Liposome Company Enter Into a Licensing Agreement for ProFlow(R), a Novel Treatment for Peripheral Arterial Disease for the China Market

FOSTER CITY, CA and TAIPEI CITY, TAIWAN: FOSTER CITY, CA and TAIPEI CITY, TAIWAN -- (Marketwired) -- 06/25/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company has entered into an agreement with Taiwan Liposo ...


Seite 39 von 66:  « ..  38 39 40  41  42  43  44  45  46  47  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z